CATHETER ABLATION
Clinical trials for CATHETER ABLATION explained in plain language.
Never miss a new study
Get alerted when new CATHETER ABLATION trials appear
Sign up with your email to follow new studies for CATHETER ABLATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a natural hormone tame atrial fibrillation after heart ablation?
Disease control Not yet recruitingThis study tests whether adding Relaxin, a natural hormone, to standard care can lower the amount of atrial fibrillation (AF) in 208 Veterans who still have symptoms despite medication and are scheduled for a heart ablation procedure. The goal is to see if Relaxin reduces oxidati…
Matched conditions: CATHETER ABLATION
Phase: PHASE1, PHASE2 • Sponsor: Deeptankar DeMazumder • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New study tests safer stroke prevention for frail seniors with AFib
Disease control Not yet recruitingThis study compares two treatments for elderly frail patients with atrial fibrillation (AFib) who are at high risk for both stroke and bleeding. One group gets a heart procedure (catheter ablation) plus a device to close off a part of the heart (left atrial appendage occlusion), …
Matched conditions: CATHETER ABLATION
Phase: NA • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
Chatbot could transform heart recovery monitoring
Symptom relief Not yet recruitingThis study tests whether a WhatsApp-based chatbot is a practical and helpful way for people to report symptoms and health updates after atrial fibrillation ablation. About 76 adults who had the procedure will either use the chatbot or get standard follow-up care for 3 months. The…
Matched conditions: CATHETER ABLATION
Phase: NA • Sponsor: Ana Rita Londral, PhD • Aim: Symptom relief
Last updated May 11, 2026 20:41 UTC